Advertisement

Topics

Allergan Receives FDA Approval For Label Expansion Of VRAYLAR

08:17 EST 13 Nov 2017 | FinanzNachrichten

WASHINGTON (dpa-AFX) - Allergan plc (AGN) announced the U.S. FDA has approved the supplemental New Drug Application (sNDA) for VRAYLAR (cariprazine) for the maintenance treatment of adults with sc...

Original Article: Allergan Receives FDA Approval For Label Expansion Of VRAYLAR

NEXT ARTICLE

More From BioPortfolio on "Allergan Receives FDA Approval For Label Expansion Of VRAYLAR"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...